Product Information

DILTIAZEM 12HR ER 90 MG CAP is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $1.7051 per EA under NDC 50742056501. Its NADAC has been published 48 times since Dec 24, 2025.

FDA first approved this application on Jul 2, 2025. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DILTIAZEM 12HR ER 90 MG CAP

diltiazem hydrochloride
$1.7051per EA

Strength

90 mg/1

NDC

50742056501

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DILTIAZEM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA218032

FDA Approved

7/2/2025

TE Code

AB1

On Market Since

7/3/2025

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for DILTIAZEM 12HR ER 90 MG CAP has been published 48 times since Dec 24, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$1.7051 per EA
All-time high$1.8385 (Mar 11, 2026)
All-time low$1.6614 (Sep 23, 2026)
52-week high$1.8385
52-week low$1.6614
Median price$1.7768
Average price$1.7726
Largest weekly change-7.7% (Sep 23, 2026)
Weeks tracked48
Tracking sinceDec 24, 2025

Price History

1W

-2.6%

1M

+2.6%

3M

-5.2%

6M

+0.1%

1Y

N/A

3Y

N/A

5Y

N/A

All

-0.4%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DILTIAZEM 12HR ER 90 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 12HR ER 90 MG CAP, manufactured by Ingenus Pharmaceuticals LLC, is $1.7051 per EA (NDC 50742056501), effective Nov 18, 2026.

How has the price of DILTIAZEM 12HR ER 90 MG CAP changed over time?

Over the history we have for it, the NADAC for DILTIAZEM 12HR ER 90 MG CAP has held within roughly two percent of its current level. It has been tracked across 48 weekly CMS publications since Dec 24, 2025.

What are the highest and lowest recorded NADAC prices for DILTIAZEM 12HR ER 90 MG CAP?

Since Dec 24, 2025, the NADAC for DILTIAZEM 12HR ER 90 MG CAP has ranged from a low of $1.6614 (Sep 23, 2026) to a high of $1.8385 (Mar 11, 2026), with a median of $1.7768 per EA.

Are there cheaper alternatives to DILTIAZEM 12HR ER 90 MG CAP?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DILTIAZEM 12HR ER 90 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures DILTIAZEM 12HR ER 90 MG CAP?

DILTIAZEM 12HR ER 90 MG CAP (NDC 50742056501) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.